Blanket Purchase Agreement 36F79722D0128-36C24522A0025
Award Date
7/29/22
Last Date to Order
7/28/26
Federal Agency
Veterans Integrated Service Network 5
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic products, to provide COAGUCHEK test strips, quality control reagents, and associated testing supplies. The contract has a total ceiling value of $235,034.34 and a period of performance through November 2024. Roche Diagnostics was awarded this single-award BPA under the GSA Schedule 65-VII for...
The Department of Veterans Affairs Veterans Health Administration (VA - VHA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation under the company's General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. The BPA, valued at up to $590,974.95 over a five-year period, will provide the VA's Veterans Integrated Service Network (VISN) 23 laboratory with INR test strips and diabetes testing supplies. Two task orders have...
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in vitro diagnostics, reagents, and test supplies under the General Services Administration (GSA) Federal Supply Schedule 65-VII. The 5-year master BPA, with a ceiling value of $217,396.88, establishes a streamlined ordering mechanism for the VA's Veterans Integrated Service...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA has a ceiling value of $139,514.30 and a period of performance through November 30, 2029. It was awarded on a sole source basis to provide Roche Coaguchek Strips, Controls, BPA Plus RALS Modules, and Device Charges to the VA's Veterans...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide ROCHE POC/INR testing, RALS software, and accessories. The single-award BPA, valued at over $7 million, has a period of performance through February 28, 2030. This contract establishes a long-term vehicle for the VA to acquire a variety of Roche's in vitro diagnostics, reagents, laboratory instruments, and associated...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $5.5 million, single-award BPA has an ultimate completion date of September 30, 2029 and was established under the GSA's "Critical Analyzers, Laboratory (FSS-66-III)" schedule contract. Under this BPA, Roche Diagnostics...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,041,901.25, allows the VA network to acquire CPRR microbiology reagents from Roche on an as-needed basis over the contract's term through September...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) has awarded Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, a Blanket Purchase Agreement (BPA) under the General Services Administration (GSA) Schedule 65-VII for Invitro Diagnostics, Reagents, and Test Kits. The BPA has a period of performance from April 1, 2024 to March 31, 2029 with a potential value of $250,000.00. Through this IDV contract, the VA VHA will acquire WTX COAGUCHEK CPT WAIVED...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a 5-year Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation for the provision of Point-of-Care (POC) Coagulation Testing services. The contract, valued at up to $234,500, will cover the supply of Roche's coagulation testing meters, associated supplies, reagents, network connections, service, maintenance, and parts required to produce patient test results. This sole-source procurement...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The initial BPA call valued at $744,714.52 is for the supply of a VCB Immunoassay/Chemistry Automation Line, which supports the VA's provision of clinical chemistry, immunochemistry, and other laboratory testing capabilities at its hospitals and...